Cancer Genomics and Epigenomics
Date and time: | 09.00-17.30
Venue: Auditorium, IJC Building, Campus Can Ruti
The cancer cell genome accumulates numerous genetic and epigenetic alterations and the role of these genome alterations in cancer initiation and progression is an avenue of active research.
In the 3rd PMPPC Conference outstanding international scientists from basic to clinical aspects of these research fields will discuss recent progress in studies on cancer genetics-genomics and epigenetics-epigenomics.
Registration is free but spaces are limited and only registered delegates will be admitted.
Program of Predictive and Personalized Medicine of Cancer (PMPPC) of the Institute of Research Germans Trias I Pujol (IGTP)
Program of Predictive and Personalized Medicine of Cancer (PMPPC) of the Institute of Research Germans Trias I Pujol (IGTP), and the Institute for Leukemia Research Jose Carreras (IJC)
10.00- 11:20 Session 1
Chairman: Sergio Alonso, Chair
10.00-10.40 Webster Cavenee (UCSD, San Diego, USA
PTEN Mediates Response to Radiation
10.40-11.20 Sergi Castellví (IDIBAPS, Barcelona, Spain)
Genetic predisposition to colorectal cancer
11.20-11.40 Coffee break
11:40-13:00 Session 2
Chairman: Miquel A. Peinado
11.40-12.20 Travis Stracker (IRB, Barcelona)
The Tousled like kinases suppress cGAS-STING mediated immune signalling in cancer
12.20-13.00 Manel Esteller (PEBC, Barcelona, Spain)
Cancer Epigenetics. from Knowledge to Applications
14.00 – 17.00 Session 3
Chairman Tanya Vavouri
14.00-14:40 Carolina Armengol (PMPPC-IGTP, Barcelona, Spain)
Genomic and Epigenomic study of Hepatoblastoma
14:40-15.20 Victor Corces (Emory University, Atlanta, USA)
Mechanisms of Transgenerational Inheritance of Obesity Epiphenotypes
15.20-15.40 Coffee Break
15.40-16.00 Session 4
Chairman Lorenzo Pasquali
16.00-16.40 Manuel Perucho (PMPPC-IGTP, Barcelona, Spain)
The genetics and epigenetics chronologies and hierarchies of colon cancer
16.40-17.20 Carlo Croce (University of Ohio, USA)
MicroRNA expression to discover targets for cancer treatment".
17.20 Closing Remarks
Sign up here The conference is free but places are limited and registration is required.